{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:36:51Z","timestamp":1787697411021,"version":"build-2784847793"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:00:00Z","timestamp":1597104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01780","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T04:31:03Z","timestamp":1597120263000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Conformationally Altered C-Reactive Protein Capable of Binding to Atherogenic Lipoproteins Reduces Atherosclerosis"],"prefix":"10.3389","volume":"11","author":[{"given":"Asmita","family":"Pathak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas P.","family":"Thewke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alok","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat Rev Dis Primers."},{"key":"B2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1146\/annurev.immunol.021908.132620","article-title":"Immune and inflammatory mechanisms of atherosclerosis","volume":"27","author":"Galkina","year":"2009","journal-title":"Annu Rev Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0021-9150(96)06035-2","article-title":"Does an acidic pH explain why low-density lipoprotein is oxidised in atherosclerotic lesions?","volume":"129","author":"Leake","year":"1997","journal-title":"Atherosclerosis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1161\/01.ATV.19.4.870","article-title":"Evidence of hypoxic areas within the arterial wall in vivo","volume":"19","author":"Bj\u00f6rnheden","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0021-9150(02)00018-7","article-title":"pH heterogeneity of human and rabbit atherosclerotic plaques; a new insight into detection of vulnerable plaque","volume":"164","author":"Naghavi","year":"2002","journal-title":"Atherosclerosis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"37449","DOI":"10.1074\/jbc.M508565200","article-title":"Decrease in pH strongly enhances binding of native, proteolyzed, lipolyzed, and oxidized low density lipoprotein particles to human aortic proteoglycans","volume":"280","author":"Sneck","year":"2005","journal-title":"J Biol Chem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"4932","DOI":"10.1091\/mbc.e09-07-0559","article-title":"Macrophages create an acidic extracellular hydrolytic compartment to digest aggregated lipoproteins","volume":"20","author":"Haka","year":"2009","journal-title":"Mol Biol Cell."},{"key":"B8","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation","volume":"340","author":"Gabay","year":"1999","journal-title":"N Engl J Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S0002-9440(10)61202-3","article-title":"C-reactive protein in atherosclerotic lesions: Its origin and pathophysiological significance","volume":"167","author":"Sun","year":"2005","journal-title":"Am J Pathol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2174\/187152910793743841","article-title":"Atherosclerosis-related functions of C-reactive protein","volume":"10","author":"Agrawal","year":"2010","journal-title":"Cardiovasc Haematol Disord Drug Targets."},{"key":"B11","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3181\/00379727-136-35323","article-title":"Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide","volume":"136","author":"Volanakis","year":"1971","journal-title":"Proc Soc Exp Biol Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0969-2126(99)80023-9","article-title":"The physiological structure of human C-reactive protein and its complex with phosphocholine","volume":"7","author":"Thompson","year":"1999","journal-title":"Structure."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.2741\/4642","article-title":"Enzymatically modified LDL, atherosclerosis and beyond: paving the way to acceptance","volume":"23","author":"Torzewski","year":"2018","journal-title":"Front Biosci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1161\/01.ATV.19.10.2348","article-title":"Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation","volume":"19","author":"Bhakdi","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"13043","DOI":"10.1073\/pnas.192399699","article-title":"C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: phosphorylcholine of oxidized phospholipids","volume":"99","author":"Chang","year":"2002","journal-title":"Proc Natl Acad Sci USA."},{"key":"B16","doi-asserted-by":"publisher","first-page":"319215","DOI":"10.1155\/2014\/319215","article-title":"Recognition functions of pentameric C-reactive protein in cardiovascular disease","volume":"2014","author":"Agrawal","year":"2014","journal-title":"Mediators Inflamm."},{"key":"B17","unstructured":"Identification of acidic pH-dependent ligands of pentameric C-reactive protein3623544\n            HammondDJJr\n            SinghSK\n            ThompsonJA\n            BeelerBW\n            Rusi\u00f1olAE\n            PangburnMK\n          10.1074\/jbc.M110.14202620843812J Biol Chem.2852010"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3550","DOI":"10.1074\/jbc.M111.310011","article-title":"Exposing a hidden functional site of C-reactive protein by site-directed mutagenesis","volume":"287","author":"Singh","year":"2012","journal-title":"J Biol Chem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1074\/jbc.M116.773176","article-title":"Functional transformation of C-reactive protein by hydrogen peroxide","volume":"292","author":"Singh","year":"2017","journal-title":"J Biol Chem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1096\/fj.06-6722com","article-title":"Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRPm","volume":"21","author":"Ji","year":"2007","journal-title":"FASEB J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"14188","DOI":"10.1038\/ncomms14188","article-title":"Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites","volume":"8","author":"Braig","year":"2017","journal-title":"Nat Commun."},{"key":"B22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.molimm.2018.09.021","article-title":"Acidic pH promotes oxidation-induced dissociation of C-reactive protein","volume":"104","author":"Li","year":"2018","journal-title":"Mol Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/978-3-030-41769-7_20","article-title":"C-reactive protein and its structural isoforms: an evolutionary conserved marker and central player in inflammatory diseases and beyond","volume":"94","author":"McFadyen","year":"2020","journal-title":"Subcell Biochem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"4316","DOI":"10.4049\/jimmunol.180.6.4316","article-title":"C-reactive protein-bound enzymatically modified low-density lipoprotein does not transform macrophages into foam cells","volume":"180","author":"Singh","year":"2008","journal-title":"J Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.3389\/fimmu.2019.01655","article-title":"Functionality of C-reactive protein for atheroprotection","volume":"10","author":"Singh","year":"2019","journal-title":"Front Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"43116","DOI":"10.1074\/jbc.M112.427310","article-title":"The phosphocholine-binding pocket on C-reactive protein is necessary for initial protection of mice against pneumococcal infection","volume":"287","author":"Gang","year":"2012","journal-title":"J Biol Chem."},{"key":"B27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.atherosclerosis.2010.07.060","article-title":"Cannabinoid receptor type 2 (CB2) deficiency alters atherosclerotic lesion formation in hyperlipidemic Ldlr-null mice","volume":"213","author":"Netherland","year":"2010","journal-title":"Atherosclerosis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to imageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods."},{"key":"B29","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/prca.201200064","article-title":"Improved protein extraction and protein identification from archival formalin-fixed paraffin-embedded human aortas","volume":"7","author":"Fu","year":"2013","journal-title":"Proteomics Clin Appl."},{"key":"B30","first-page":"17","article-title":"Immunochemical cross-reactions between pentraxins of different species","volume":"62","author":"Maudsley","year":"1987","journal-title":"Immunology."},{"key":"B31","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1161\/01.CIR.0000114526.50618.24","article-title":"C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice","volume":"109","author":"Paul","year":"2004","journal-title":"Circulation."},{"key":"B32","doi-asserted-by":"publisher","first-page":"8309","DOI":"10.1073\/pnas.0503202102","article-title":"Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice","volume":"102","author":"Hirschfield","year":"2005","journal-title":"Proc Natl Acad Sci USA."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1161\/01.ATV.0000171983.95612.90","article-title":"Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer?","volume":"25","author":"Reifenberg","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1161\/CIRCULATIONAHA.105.556530","article-title":"Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice","volume":"112","author":"Schwedler","year":"2005","journal-title":"Circulation."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1161\/01.ATV.0000171992.36710.1e","article-title":"No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden\/human C-reactive protein transgenic mice","volume":"25","author":"Trion","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"13768","DOI":"10.1073\/pnas.0706027104","article-title":"Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia","volume":"104","author":"Kovacs","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"B37","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.atherosclerosis.2007.05.010","article-title":"Transgenic human CRP is not pro-atherogenic, pro-atherothrombotic or pro-inflammatory in apoE-\/- mice","volume":"196","author":"Tennent","year":"2008","journal-title":"Atherosclerosis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1160\/TH07-10-0595","article-title":"No effect of C-reactive protein on early atherosclerosis in LDLR-\/-\/human C-reactive protein transgenic mice","volume":"99","author":"Torzewski","year":"2008","journal-title":"Thromb Haemost."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1161\/CIRCULATIONAHA.109.872796","article-title":"Human C-reactive protein does not promote atherosclerosis in transgenic rabbits","volume":"120","author":"Koike","year":"2009","journal-title":"Circulation."},{"key":"B40","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3181\/0812-RM-347","article-title":"Continously-infused human C-reactive protein is neither proatherosclerotic nor proinflammatory in apolipoprotein E-deficient mice","volume":"234","author":"Ortiz","year":"2009","journal-title":"Exp Biol Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"6272","DOI":"10.1074\/jbc.M110.161414","article-title":"No reduction of atherosclerosis in C-reactive protein (CRP)-deficient mice","volume":"286","author":"Teupser","year":"2011","journal-title":"J Biol Chem."},{"key":"B42","doi-asserted-by":"publisher","first-page":"979132","DOI":"10.1155\/2014\/979132","article-title":"Effects of antisense oligonucleotides against C-reactive protein on the development of atherosclerosis in WHHL rabbits","volume":"2014","author":"Yu","year":"2014","journal-title":"Mediators Inflamm."},{"key":"B43","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3389\/fimmu.2018.00430","article-title":"C-reactive protein in atherothrombosis and angiogenesis","volume":"9","author":"Badimon","year":"2018","journal-title":"Front Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.3390\/molecules24112062","article-title":"The multiple faces of C-reactive protein - physiological and pathophysiological implications in cardiovascular disease","volume":"24","author":"Boncler","year":"2019","journal-title":"Molecules."},{"key":"B45","doi-asserted-by":"publisher","first-page":"26293","DOI":"10.1074\/jbc.M002423200","article-title":"Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in low density lipoprotein receptor-deficient mice","volume":"275","author":"Babaev","year":"2000","journal-title":"J Biol Chem."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1161\/hq1001.096724","article-title":"Effect of \u03b3-irradiation and bone marrow transplantation on atherosclerosis in LDL receptor-deficient mice","volume":"21","author":"Schiller","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1161\/hq0302.104905","article-title":"Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-\/- mice","volume":"22","author":"King","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1161\/01.ATV.0000105054.43931.f0","article-title":"Site specificity of atherosclerosis: Site-selective responses to atherosclerotic modulators","volume":"24","author":"VanderLaan","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1161\/ATVBAHA.108.172270","article-title":"Site-specific effects of PECAM-1 on atherosclerosis in LDL receptor-deficient mice","volume":"28","author":"Goel","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1055\/s-0038-1657753","article-title":"Chondroitin sulphate attenuates atherosclerosis in apoE knockout mice involving cellular regulation of the inflammatory response","volume":"118","author":"Melgar-Lesmes","year":"2018","journal-title":"Thromb Haemost."},{"key":"B51","doi-asserted-by":"publisher","first-page":"8795","DOI":"10.1074\/jbc.M115.695023","article-title":"An intrinsically disordered motif mediates diverse actions of monomeric C-reactive protein","volume":"291","author":"Li","year":"2016","journal-title":"J Biol Chem."},{"key":"B52","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3389\/fimmu.2020.00583","article-title":"Cellular folding determinants and conformational plasticity of native C-reactive protein","volume":"11","author":"Lv","year":"2020","journal-title":"Front Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.molimm.2005.06.045","article-title":"Statins and nitric oxide reduce C-reactive protein production while inflammatory conditions persist","volume":"43","author":"Voleti","year":"2006","journal-title":"Mol Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.molimm.2004.09.028","article-title":"CRP after 2004","volume":"42","author":"Agrawal","year":"2005","journal-title":"Mol Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"17281","DOI":"10.1073\/pnas.1202244109","article-title":"Early environments and the ecology of inflammation","volume":"109","author":"McDade","year":"2012","journal-title":"Proc Natl Acad Sci USA."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01780\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T04:31:08Z","timestamp":1597120268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01780\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,11]]},"references-count":55,"alternative-id":["10.3389\/fimmu.2020.01780"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01780","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,11]]},"article-number":"1780"}}